Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Jun 5 2026 UPDATED 9:30 AM

Full Issue

Experimental Antibody Treatment Is At The Ready For Americans Exposed To Ebola

The Biomedical Advanced Research and Development Authority is coordinating a shipment of monoclonal antibodies “for potential use in high-risk Americans exposed to the virus,” an HHS spokesperson revealed. MBP-134 would be used under the FDA’s “investigational use mechanisms,” a measure that allows unlicensed treatments to be used in emergency situations, Stat reports.

Stat: HHS Confirms Americans With High-Risk Ebola Exposures Will Have Access To Experimental Therapy

Americans who have high-risk exposures to Ebola in the current outbreak in Central Africa will have access to an antibody treatment that has shown great promise in animal testing but hasn’t yet undergone a clinical trial to show whether it is efficacious in people, the Department of Health and Human Services confirmed Thursday. The antibody treatment, known as MBP-134, is made by San Diego-based Mapp Biopharmaceuticals, with funding from the Biomedical Advanced Research and Development Authority, an agency within HHS that helps develop medical countermeasures for rare and emerging diseases, and biological threats. (Branswell, 6/4)

The Hill: CDC's Jay Bhattacharya Defends Donald Trump's Ebola Response

Acting Director of the Centers for Disease Control and Prevention (CDC) Jay Bhattacharya defended the Trump administration’s response to the Ebola outbreak Thursday, writing in The Wall Street Journal that the measures being taken are scientifically stronger than those implemented during the COVID-19 pandemic. Bhattacharya said the COVID-19 public health response measures such as “lockdowns,” school closures, and mask and vaccine mandates “made little scientific sense.” (Weixel, 6/4)

The Hill: House Report Blames Trump's USAID Shutdown For 600,000 Deaths, Ebola Spread

The Trump administration’s decision to kill the U.S. Agency for International Development (USAID) likely contributed to 600,000 “entirely preventable” deaths, left the globe faltering in responding to the latest Ebola outbreak and let U.S. adversaries increase their standing in the developing world, a report from House Oversight Democrats finds. The report, issued Thursday, offers one of the most detailed looks yet at the impact of shutting the agency, from the firing of over 10,000 federal workers and contractors to a surge in the spread of diseases like HIV and malaria that had been USAID priorities for decades. (Beitsch, 6/4)

On the spread of Ebola —

WISN: Milwaukee Health Dept. Monitoring 3 'Low-Risk' Travelers For Ebola As A Precaution 

The City of Milwaukee Health Department says it is monitoring three "very low-risk individuals" as a precaution for Ebola, as of June 4. A spokesperson described the three people as "travelers," coming back from Africa. (Schmitz, 6/4)

CIDRAP: Ebola Spreads To Area Under Islamic State Control As Cases Mount

The Ebola outbreak in the Democratic Republic of the Congo (DRC) has reached Mambasa, a part of the country run by Islamic State militants, the Wall Street Journal reported today. Health workers do not travel to the area, which is chaotic and violent, making containment and contact tracing impossible, sources told the paper. (Soucheray, 6/4)

ABC News: Aid Organization Says Trust Is Key In Combatting Ebola Outbreak As Cases Grow

As a deadly Ebola outbreak in the Democratic Republic of the Congo continues to spread, an aid organization says trust is key to beating back the virus. At the time of publication, 363 cases of Ebola and 62 deaths have been confirmed, according to the Congo Ministry of Health and the Centers for Disease Control and Prevention (CDC), with more than 4,200 contacts under follow-up. In neighboring Uganda, 16 cases and one death have been confirmed, according to the Ugandan Ministry of Health. (Kekatos, Jovanovic and Magee, 6/4)

KFF Health News: ‘We Live With Fear’: In Congo, Doctors Face Ebola With Little Protection

Harrowing scenes are unfolding at health facilities at the epicenter of an Ebola outbreak in the Democratic Republic of Congo. A 25-year-old midwife and a doctor in his early 30s are sick with Ebola symptoms, including fevers and severe joint pain, said their colleague Elisabeth Furaha, the medical director at SOFEPADI’s Karibuni Wa Mama Medical Center in the northeastern province of Ituri. (Maxmen, 6/5)

Bloomberg: Ebola Outbreak 2026 Unlikely To Become Pandemic, Peter Piot Says

When Peter Piot first encountered the Ebola virus, it was unknown to science. Nearly 50 years later, as a new outbreak spreads through parts of Central Africa and governments respond with travel restrictions and quarantine measures, the Belgian scientist remains one of the world’s leading authorities on the disease. He discusses how Ebola is dangerous but difficult to spread, as well as the challenges of controlling outbreaks in conflict zones — and lessons the world still hasn’t learned from Covid-19. (Husain, 6/5)

The New York Times: How Gold Is Driving The Spread Of Ebola 

For over a century, gold has been the lifeblood of Mongbwalu, a remote hill town in Ituri province that draws people looking for work from across Congo and beyond. But now Mongbwalu is at the epicenter of the devastating Ebola outbreak sweeping this region, and gold is helping to drive it. Experts now believe that the outbreak, already the third largest on record, began in Mongbwalu as early as February. Yet the authorities failed to detect it until May 15. By the time a crisis was declared, the Bundibugyo virus had already been spreading for weeks through Mongbwalu’s gold mines. (Walsh, 6/5)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, June 5
  • Thursday, June 4
  • Wednesday, June 3
  • Tuesday, June 2
  • Monday, June 1
  • Friday, May 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF